All stocks Β· DECIPHER
DL

DECIPHER LABS LIMITED

DECIPHER BSE Drug Manufacturers - Specialty & Generic Healthcare

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharma…

ISIN INE643N01012
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap6 Cr
P/Eβ€”
Div Yield0.00 %
Book Valueβ‚Ή20.50
52w Highβ‚Ή11.20
52w Lowβ‚Ή5.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 2.41 3.60 3.21 4.31 2.92 3.50 5.80 5.87 7.44 10.59 8.29 7.49 9.51
Expenses 4.57 3.37 3.64 4.19 6.24 10.08 6.43 7.20 6.13 9.38 8.16 9.66 9.65
Operating Profit -2.16 0.23 -0.43 0.12 -3.32 -6.58 -0.63 -1.33 1.31 1.21 0.13 -2.17 -0.14
OPM % -89.63 6.39 -13.40 2.78 -113.70 -188.00 -10.86 -22.66 17.61 11.43 1.57 -28.97 -1.47
Other Income 0.10 0.17 0.02 0.02 0.01 0.87 0.17 0.12 0.16 0.27 0.00 0.14 0.01
Depreciation 0.13 0.15 0.13 0.13 0.12 0.13 0.12 0.12 0.11 0.11 0.12 0.11 0.11
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.01
Profit before tax -2.19 0.25 -0.54 0.01 -3.43 -5.84 -0.58 -1.33 1.36 1.16 0.01 -2.14 -0.25
Tax % 0.00 244.00 1.85 0.00 0.00 -29.62 1.72 0.00 30.15 -3.45 0.00 -9.35 280.00
Net Profit -2.19 -0.36 -0.54 0.02 -3.43 -4.11 -0.59 -1.33 0.95 1.20 0.01 -1.94 -0.95
EPS in Rs -2.17 -0.36 -0.53 0.02 -3.40 -4.07 -0.58 -1.32 0.94 1.19 0.01 -1.92 -0.94

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales 14.0522.6135.8845.5765.3255.5623.998.061.02
Expenses 17.4424.5036.5649.7459.2952.0821.477.610.95
Operating Profit -3.39-1.89-0.68-4.176.033.482.520.450.07
OPM % -24.13-8.36-1.90-9.159.236.2610.505.586.86
Other Income 0.22-4.020.160.927.670.650.270.000.11
Interest 0.000.000.240.480.481.170.770.010.00
Depreciation 0.520.480.450.430.870.820.560.000.00
Profit before tax -3.69-6.39-1.21-4.1612.352.141.460.440.18
Tax % -16.26-20.5038.02-35.587.8534.5825.349.090.00
Net Profit -3.08-5.08-1.68-2.6811.381.401.100.410.18
EPS in Rs -3.05-5.03-1.66-2.6511.271.391.090.510.22
Dividend Payout % 0.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital 10.1010.1010.1010.1010.1010.1010.108.008.00
Reserves 10.5712.7611.7613.1114.073.592.46-5.47-5.88
Borrowings 0.500.240.000.9510.3216.3911.280.200.13
Other Liabilities 3.162.6611.774.017.468.6411.553.610.71
Total Liabilities 24.3325.7633.6328.1741.9538.7235.396.342.96
Fixed Assets 2.532.542.913.312.834.434.980.010.00
CWIP 0.000.000.000.000.000.000.000.000.00
Investments 0.000.263.393.760.260.000.000.000.00
Other Assets 21.8022.9627.3321.1038.8634.2930.416.332.96
Total Assets 24.3325.7633.6328.1741.9538.7235.396.342.96

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Cash from Operating Activity -2.08-9.824.85-1.568.261.83-15.180.23-0.10
Cash from Investing Activity -0.243.07-1.79-4.28-1.13-0.31-0.01-0.020.00
Cash from Financing Activity 0.260.24-1.17-2.151.303.9916.360.070.09
Net Cash Flow -2.07-6.511.90-7.998.435.511.170.28-0.01
Free Cash Flow -2.32-9.884.79-2.348.061.52-15.420.22-0.10
CFO/OP % 61.00520.00-713.0037.00137.0053.00-602.0051.00-143.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Debtor Days 67.5468.1279.3578.9071.4776.67222.44156.69211.13
Inventory Days β€”β€”0.00β€”β€”β€”β€”19.7091.25
Days Payable β€”β€”β€”β€”β€”β€”β€”192.66511.00
Cash Conversion Cycle 67.5468.1279.3578.9071.4776.67222.44-16.27-208.62
Working Capital Days 395.40247.4836.5261.6765.43-11.50-2.1399.63751.47
ROCE % -16.67-4.67-3.099.4539.7412.2816.7918.07β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 16.43 16.43 16.43 16.43 16.43 16.43 16.43 16.43 16.43 16.43 16.43 16.43
Public 83.57 83.59 83.58 83.57 83.57 83.56 83.58 83.57 83.57 83.58 83.57 83.57
No. of Shareholders 29,368 29,596 29,825 30,174 30,512 31,182 31,482 31,838 32,833 33,371 34,511 35,728

Corporate Actions

2 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 19 Sep 2011 01 Oct 2011 β€” β€” Reduction of Capital
Other 19 Sep 2011 01 Oct 2011 β€” β€” Consolidation of Shares

Announcements

5 filings